The recently introduced SAAR (Sum of AST/ALT Ratios) score may serve as a novel marker for predicting postoperative outcomes.<h4>Methods</h4>This retrospective single-center study included 213 patients undergoing liver resection for HCC between January 2007 and October 2024. The gene discussed is GPT; the disease is hepatocellular carcinoma.